Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7e29d5f3dd73938f1ad5248ca11fbb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f75cc61295b6c8882ca116d5fb634dca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e45cde95d5a9f979ffdbc9e940715bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9faf0ff03b05a5395781acdee289410 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 |
filingDate |
2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4b9025ea6aef601ee11b186cc60e27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0dc67bf8027af2bea30ed6c70730b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f65c4b379e7f9583e63138bc8066d63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c88d55246a91dd687e8880ae34a45a40 |
publicationDate |
2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009111772-A1 |
titleOfInvention |
Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety |
abstract |
The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a β-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898315-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898315-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102276500-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102452988-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102452988-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013170757-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055369-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014142117-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685382-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022237456-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108314657-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013542210-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103420923-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617750-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013225811-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9321759-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295676-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104761507-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846912-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233995-B2 |
priorityDate |
2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |